Diagnostic utility of 18F-FDG PET/CT in inflammation of unknown origin

Clinical Nuclear Medicine

Volumn 39, Issue 5, 2014, Pages 419-425

  Balink, Hans ^a   Bennink, Roel J ^b   Veeger, Nic J G M ^c   Van Eck Smit, Berthe L F ^b   Verberne, Hein J ^b  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

inflammation of unknown origin; IUO; unexplained inflammatory syndrome

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BODY TEMPERATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INFLAMMATION OF UNKNOWN ORIGIN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MULTICENTER STUDY (TOPIC); PET-CT SCANNER; PREDICTIVE VALUE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; METABOLISM; MULTICENTER STUDY; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84898542181     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000000423     Document Type: Article

References (34)

1. Durack DT, Street AC. Fever of unknown originVreexamined and redefined. Curr Clin Top Infect Dis. 1991;11:35-51.
2. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008; 454:428-435.
3. Vanderschueren S, Del BE, Ruttens D, et al. Inflammation of unknown origin versus fever of unknown origin: two of a kind. Eur J Intern Med. 2009;20: 415-418.
4. Perrin AE, Goichot B, Andres E, et al. [Development and long-term prognosis of unexplained persistent inflammatory biologic syndromes]. Rev Med Interne. 2002;23:683-689.
5. Bleeker-Rovers CP, Vos FJ, de Kleijn EM, et al. A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore). 2007;86:26-38.
6. Sheng JF, Sheng ZK, Shen XM, et al. Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with fever of unknown origin. Eur J Intern Med. 2011;22:112-116.
7. Ferda J, Ferdova E, Zahlava J, et al. Fever of unknown origin: a value of (18)F-FDG-PET/CTwith integrated full diagnostic isotropic CT imaging. Eur J Radiol. 2009;73:518-525.
8. Balink H, Collins J, Bruyn GA, et al. F-18 FDG PET/CT in the diagnosis of fever of unknown origin. Clin Nucl Med. 2009;34:862-868.
9. Keidar Z, Gurman-Balbir A, Gaitini D, et al. Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med. 2008;49:1980-1985.
10. Becerra Nakayo EM, Garcia Vicente AM, Soriano Castrejon AM, et al. Analysis of cost-effectiveness in the diagnosis of fever of unknown origin and the role of (18)F-FDG PET-CT: a proposal of diagnostic algorithm. Rev Esp Med Nucl Imagen Mol. 2012;31:178-186.
11. Ell PJ. The contribution of PET/CT to improved patient management. Br J Radiol. 2006;79:32-36.
12. Hooisma GA, Balink H, Houtman PM, et al. Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study. Clin Rheumatol. 2012;31:861-871.
13. Jasper N, Dabritz J, Frosch M, et al. Diagnostic value of [(18)F]-FDG PET/CT in children with fever of unknown origin or unexplained signs of inflammation. Eur J Nucl Med Mol Imaging. 2010;37:136-145.
14. Federici L, Blondet C, Imperiale A, et al. Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience. Int J Clin Pract. 2010;64:55-60.
15. Petersdorf RG. Fever of unknown origin. An old friend revisited. Arch Intern Med. 1992;152:21-22.
16. Pizzo PA. Fever in immunocompromised patients. N Engl J Med. 1999;341: 893-900.
17. de Kleijn EM, Vandenbroucke JP, van der Meer JW. Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore). 1997;76:392-400.
18. Affronti M, Mansueto P, Soresi M, et al. Low-grade fever: how to distinguish organic from non-organic forms. Int J Clin Pract. 2010;64:316-321.
19. Meller J, Altenvoerde G, Munzel US, et al. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med. 2000;27:1617-1625.
20. Blockmans D, Knockaert D, Maes A, et al. Clinical value of [(18)F]fluorodeoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis. 2001;32:191-196.
21. Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun. 2001;22:779-783.
22. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, et al. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging. 2004;31:29-37.
23. Kjaer A, Lebech AM, Eigtved A, et al. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004;31:622-626.
24. Buysschaert I, Vanderschueren S, Blockmans D, et al. Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med. 2004;15:151-156.
25. Bleeker-Rovers CP, Vos FJ, Mudde AH, et al. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging. 2007;34: 694-703.
26. Jaruskova M, Belohlavek O. Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states. Eur J Nucl Med Mol Imaging. 2006;33:913-918.
27. Pelosi E, Skanjeti A, Penna D, et al. Role of integrated PET/CT with [(1)(8)F]-FDG in the management of patients with fever of unknown origin: a single-centre experience. Radiol Med. 2011;116:809-820.
28. Crouzet J, Boudousq V, Lechiche C, et al. Place of (18)F-FDG-PET with computed tomography in the diagnostic algorithm of patients with fever of unknown origin. Eur J Clin Microbiol Infect Dis. 2012;31:1727-1733.
29. Ostberg G. An arteritis with special reference to polymyalgia arteritica. Acta Pathol Microbiol Scand Suppl 1973;237:1-59.
30. Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131-2135.
31. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875-880
32. Bertagna F, Treglia G, Leccisotti L, et al. [18F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience. Jpn J Radiol. 2012;30:415-421.
33. Meller J, Strutz F, Siefker U, et al. Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI. Eur J Nucl Med Mol Imaging. 2003;30:730-736.
34. Adams H, Raijmakers P, Smulders Y. Polymyalgia rheumatica and interspinous FDG uptake on PET/CT. Clin Nucl Med. 2012;37:502-505.